NDC 71335-2261 – Acyclovir

Acyclovir 200 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC71335-2261

Product details

Brand name
Acyclovir
Generic name
Acyclovir
Labeler
Bryant Ranch Prepack
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA204313
Marketed since
August 23, 2019
Listing expires
December 31, 2026
Pharmacologic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Acyclovir →

Package NDC codes (10)

Package NDCDescriptionSince
71335-2261-090 CAPSULE in 1 BOTTLE (71335-2261-0)Oct 27, 2023
71335-2261-130 CAPSULE in 1 BOTTLE (71335-2261-1)Oct 27, 2023
71335-2261-225 CAPSULE in 1 BOTTLE (71335-2261-2)Oct 27, 2023
71335-2261-335 CAPSULE in 1 BOTTLE (71335-2261-3)Oct 27, 2023
71335-2261-450 CAPSULE in 1 BOTTLE (71335-2261-4)Oct 27, 2023
71335-2261-5100 CAPSULE in 1 BOTTLE (71335-2261-5)Oct 27, 2023
71335-2261-640 CAPSULE in 1 BOTTLE (71335-2261-6)Oct 27, 2023
71335-2261-760 CAPSULE in 1 BOTTLE (71335-2261-7)Oct 27, 2023
71335-2261-8120 CAPSULE in 1 BOTTLE (71335-2261-8)Oct 27, 2023
71335-2261-920 CAPSULE in 1 BOTTLE (71335-2261-9)Oct 27, 2023

Other Acyclovir products